EPITHELIAL OVARIAN CANCER
Clinical trials for EPITHELIAL OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new EPITHELIAL OVARIAN CANCER trials appear
Sign up with your email to follow new studies for EPITHELIAL OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough cancers: experimental drug targets tumors resistant to standard therapy
Disease control OngoingThis study tests a new drug called SKB264 in people with advanced solid tumors (like lung, breast, or ovarian cancer) that have not responded to standard treatments. The goal is to find the safest dose and see if the drug can shrink tumors. About 1,410 participants will receive t…
Matched conditions: EPITHELIAL OVARIAN CANCER
Phase: PHASE1, PHASE2 • Sponsor: Klus Pharma Inc. • Aim: Disease control
Last updated May 17, 2026 00:32 UTC
-
New gene therapy shows promise in ovarian cancer fight
Disease control OngoingThis study tests a new treatment called IMNN-001, a gene therapy given directly into the abdomen, combined with standard chemotherapy for people newly diagnosed with advanced ovarian, fallopian tube, or primary peritoneal cancer. The goal is to see if the combination helps people…
Matched conditions: EPITHELIAL OVARIAN CANCER
Phase: PHASE1, PHASE2 • Sponsor: Imunon • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Heated chemo during surgery may extend life in resistant ovarian cancer
Disease control OngoingThis study tests whether combining surgery with heated chemotherapy delivered directly into the abdomen can help people with platinum-resistant ovarian cancer live longer without the disease getting worse. It includes 140 adults whose cancer has stopped responding to standard pla…
Matched conditions: EPITHELIAL OVARIAN CANCER
Phase: PHASE3 • Sponsor: National Cancer Center, Korea • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Engineered immune cells take on ovarian cancer in early trial
Disease control OngoingThis early-phase study tests a new treatment for ovarian cancer that has come back after previous therapy. The treatment uses a patient's own immune cells, which are modified in a lab to better recognize and attack cancer cells. The main goal is to find the safest dose and check …
Matched conditions: EPITHELIAL OVARIAN CANCER
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:40 UTC